In the News

Study points to possible new treatment for HER2+ breast cancer

by Traci Bratton

April 22, 2015
Print
Email

A paper by University of Alabama at Birmingham cancer researcher Eddy S. Yang, M.D., Ph.D., and colleagues has found that a significant portion of one of the subtypes — called HER2-enriched or HER2+ — has elevated expression of two proteins called PARP1 and phospho-p65.

http://www.sciencedaily.com/releases/2015/04/150415125530.htm

back to top

Media Policy Guidelines

Marketing and Communications

UAB Home

The University of Alabama at Birmingham

1720 2nd Ave South

Birmingham, AL 35294

Public Relations: (205) 934-3884

Media Specialist On Call: (205) 934-3411

Contact UAB
|
|
A-Z Site Index
|
Privacy
|
Terms of Use
|

UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.